← Back to Clinical Trials
Recruiting NCT06801535

NCT06801535 Efficacy of 3D-Printed Mouth Splints

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06801535
Status Recruiting
Phase —
Sponsor Wake Forest University Health Sciences
Condition Microstomia
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2025-02-21
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Splint

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2025-02-21 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will investigate the effectiveness of a 3D-printed mouth splint designed to increase dimensions of oral aperture and reduce disability associated with mouth contractures. The validated Mouth Impairment and Disability Assessment (MIDA) survey will be used to objectively measure patient progress in functionality and quality of life.

Eligibility Criteria

Inclusion Criteria: * Patients 2 years to 99 years of age with documented microstomia following burn injuries. * Ability to comply with prescribed home exercises and follow-up visits. Exclusion Criteria: * Cognitive or physical inability to perform the prescribed exercises. * Inability of a caretaker to be able to deliver therapy daily. * Concomitant conditions that may significantly affect oral aperture (e.g., temporomandibular joint (TMJ) disorders).

Contact & Investigator

Central Contact

Study Coordinator

✉ csuggs@wakehealth.edu

📞 3367164171

Principal Investigator

Christopher Runyan, MD, PhD

PRINCIPAL INVESTIGATOR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT06801535 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, up to 99 Years, studying Microstomia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06801535 currently recruiting?

Yes, NCT06801535 is actively recruiting participants. Contact the research team at csuggs@wakehealth.edu for enrollment information.

Where is the NCT06801535 trial being conducted?

This trial is being conducted at Winston-Salem, United States.

Who is sponsoring the NCT06801535 clinical trial?

NCT06801535 is sponsored by Wake Forest University Health Sciences. The principal investigator is Christopher Runyan, MD, PhD at Wake Forest University Health Sciences. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology